“…Therefore, a downregulation of this miRNA can lead to an increased expression of TMPRSS2 and an increased susceptibility to SARS-CoV-2 infection. In addition to this, miR-214 is known for is tumorigenic and suppressive roles in cancer, and it is also being considered as a potential biomarker and therapeutic agent [ 73 ], apart from in brain and pancreatic cancer, and melanoma were it as an oncogenic role ( Figure 2 ) [ 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 ]. Moreover, miR-98, another miRNA that targets TMPRSS2, was reported as deregulated in 14 of the 15 cancer types that are displayed in Figure 2 (it was not described in kidney cancer).…”